Scientific Letters
Discordance between creatinine and cystatin C in patients with leukemia
Discrepancia entre creatinina y cistatina C en pacientes afectos de leucemia
Manuel Vaqueiro Graña
, Diego Morante Martínez, Alejandro Zarauza Santoveña, Juan Bravo Feito, Laura Espinosa Román
Corresponding author
Servicio de Nefrología Infantil, Hospital Universitario La Paz, Madrid, Spain
Read
1772
Timeswas read the article
578
Total PDF
1194
Total HTML
Share statistics
array:24 [ "pii" => "S2341287923001655" "issn" => "23412879" "doi" => "10.1016/j.anpede.2023.04.014" "estado" => "S300" "fechaPublicacion" => "2023-09-01" "aid" => "3449" "copyright" => "Asociación Española de Pediatría" "copyrightAnyo" => "2023" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2023;99:203-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S1695403323000930" "issn" => "16954033" "doi" => "10.1016/j.anpedi.2023.04.008" "estado" => "S300" "fechaPublicacion" => "2023-09-01" "aid" => "3449" "copyright" => "Asociación Española de Pediatría" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2023;99:203-5" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "es" => array:10 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Carta científica</span>" "titulo" => "Discrepancia entre creatinina y cistatina C en pacientes afectos de leucemia" "tienePdf" => "es" "tieneTextoCompleto" => "es" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "203" "paginaFinal" => "205" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Discordance between creatinine and cystatin C in patients with leukemia" ] ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Manuel Vaqueiro Graña, Diego Morante Martínez, Alejandro Zarauza Santoveña, Juan Bravo Feito, Laura Espinosa Román" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Manuel" "apellidos" => "Vaqueiro Graña" ] 1 => array:2 [ "nombre" => "Diego" "apellidos" => "Morante Martínez" ] 2 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Zarauza Santoveña" ] 3 => array:2 [ "nombre" => "Juan" "apellidos" => "Bravo Feito" ] 4 => array:2 [ "nombre" => "Laura" "apellidos" => "Espinosa Román" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S2341287923001655" "doi" => "10.1016/j.anpede.2023.04.014" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287923001655?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403323000930?idApp=UINPBA00005H" "url" => "/16954033/0000009900000003/v1_202309041137/S1695403323000930/v1_202309041137/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S2341287923001916" "issn" => "23412879" "doi" => "10.1016/j.anpede.2023.08.009" "estado" => "S300" "fechaPublicacion" => "2023-09-01" "aid" => "3450" "copyright" => "Asociación Española de Pediatría" "documento" => "simple-article" "crossmark" => 1 "subdocumento" => "crp" "cita" => "An Pediatr (Barc). 2023;99:205-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letter</span>" "titulo" => "Cutaneous and hepatic infantile haemangiomas as a clinical manifestation of Beckwith Wiedemann syndrome" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "205" "paginaFinal" => "207" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Hemangiomas infantiles cutáneos y hepáticos como manifestación clínica de síndrome de Beckwith-Wiedemann" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:9 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "fuente" => "Absence of Doppler signal." "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 1328 "Ancho" => 1305 "Tamanyo" => 232451 ] ] "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0010" "detalle" => "Figure " "rol" => "short" ] ] "descripcion" => array:1 [ "en" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">A and B) Abdominal ultrasound scan with visualization of 10 to 15 hypoechogenic space-occupying lesions compatible with hepatic haemangioma. A Doppler signal can be seen in image B. C and D) Abdominal ultrasound scan at 4 months of treatment, in which the hepatic haemangiomas can no longer be seen.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Arantxa Muñiz de Lucas, Elena Naz Villalba, Gonzalo Manuel Botija Arcos, Elena Jaime Lara, Jose Luis López Estebaranz" "autores" => array:5 [ 0 => array:2 [ "nombre" => "Arantxa" "apellidos" => "Muñiz de Lucas" ] 1 => array:2 [ "nombre" => "Elena" "apellidos" => "Naz Villalba" ] 2 => array:2 [ "nombre" => "Gonzalo Manuel" "apellidos" => "Botija Arcos" ] 3 => array:2 [ "nombre" => "Elena" "apellidos" => "Jaime Lara" ] 4 => array:2 [ "nombre" => "Jose Luis" "apellidos" => "López Estebaranz" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403323000942" "doi" => "10.1016/j.anpedi.2023.04.009" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403323000942?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287923001916?idApp=UINPBA00005H" "url" => "/23412879/0000009900000003/v1_202309061009/S2341287923001916/v1_202309061009/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S2341287923001680" "issn" => "23412879" "doi" => "10.1016/j.anpede.2023.06.016" "estado" => "S300" "fechaPublicacion" => "2023-09-01" "aid" => "3477" "copyright" => "Asociación Española de Pediatría" "documento" => "article" "crossmark" => 1 "subdocumento" => "fla" "cita" => "An Pediatr (Barc). 2023;99:195-202" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "en" => array:12 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Special Article</span>" "titulo" => "Research ethics: From principles to practical aspects" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "195" "paginaFinal" => "202" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Ética en investigación: de los principios a los aspectos prácticos" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "Gonzalo Solis Sánchez, Guillermo Alcalde Bezhold, Iciar Alfonso Farnós" "autores" => array:3 [ 0 => array:2 [ "nombre" => "Gonzalo" "apellidos" => "Solis Sánchez" ] 1 => array:2 [ "nombre" => "Guillermo" "apellidos" => "Alcalde Bezhold" ] 2 => array:2 [ "nombre" => "Iciar" "apellidos" => "Alfonso Farnós" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S1695403323001467" "doi" => "10.1016/j.anpedi.2023.06.005" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1695403323001467?idApp=UINPBA00005H" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287923001680?idApp=UINPBA00005H" "url" => "/23412879/0000009900000003/v1_202309061009/S2341287923001680/v1_202309061009/en/main.assets" ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Scientific Letters</span>" "titulo" => "Discordance between creatinine and cystatin C in patients with leukemia" "tieneTextoCompleto" => true "saludo" => "Dear Editor:" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "203" "paginaFinal" => "205" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "Manuel Vaqueiro Graña, Diego Morante Martínez, Alejandro Zarauza Santoveña, Juan Bravo Feito, Laura Espinosa Román" "autores" => array:5 [ 0 => array:4 [ "nombre" => "Manuel" "apellidos" => "Vaqueiro Graña" "email" => array:2 [ 0 => "mvg71993@gmail.com" 1 => "manuel.vaqueiro@salud.madrid.org" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">*</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "Diego" "apellidos" => "Morante Martínez" ] 2 => array:2 [ "nombre" => "Alejandro" "apellidos" => "Zarauza Santoveña" ] 3 => array:2 [ "nombre" => "Juan" "apellidos" => "Bravo Feito" ] 4 => array:2 [ "nombre" => "Laura" "apellidos" => "Espinosa Román" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "Servicio de Nefrología Infantil, Hospital Universitario La Paz, Madrid, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Discrepancia entre creatinina y cistatina C en pacientes afectos de leucemia" ] ] "textoCompleto" => "<span class="elsevierStyleSections"><p id="par0005" class="elsevierStylePara elsevierViewall">The assessment of glomerular filtration is a necessary practice in oncological patients, given the nephrotoxicity of the drugs used for treatment and its usefulness in guiding prescribing. We present 3 cases in which there was a discrepancy between creatinine and cystatin C-based estimates in patients with a history of acute myeloid leukaemia (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>).</p><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0010" class="elsevierStylePara elsevierViewall">The first was a girl aged 11 years, with no personal or family history of renal or urinary tract disease, who, prior to initiation of treatment, exhibited abnormal levels of cystatin C as high as 2.74 mg/L (turbidimetric assay traceable to ERM-DA471/IFCC), with repeated measurements of creatinine within the normal range (0.55−0.65 mg/dL) (enzymatic assay traceable to IDMS). Blood pressure measurements were within the normal range and the patient had not lost a significant amount of weight. Blood chemistry tests ruled out thyroid disorders and the routine urinalysis revealed mild proteinuria that was likely to be due to hyperfiltration secondary to hyperhydration. Steroid therapy has not been initiated. A renal ultrasound scan showed mild nonspecific echogenicity of the renal parenchyma. Last of all, filtration was measured by means of Cr-ethylenediamine tetraacetic acid (EDTA) scintigraphy, yielding a value of 102 mL/min/1.73 m<span class="elsevierStyleSup">2</span>, which confirmed normal glomerular filtration, and the patient started treatment and has been free of nephrological complications to date.</p><p id="par0015" class="elsevierStylePara elsevierViewall">The second was a boy aged 12 years who had undergone allogeneic haematopoietic stem cell transplantation (HSCT) one year prior and was in remission at the time he was referred to our clinic due to progressive worsening of renal function as inferred by the cystatin C level (1.44 mg/L) while the creatinine level remained stable (0.43 mg/dL). This was initially attributed to different drugs: baricitinib, used for treatment of cutaneous graft versus host disease, and acyclovir used for prophylaxis. His weight and blood pressure were within the normal range. The results of the blood and urine tests were normal, thyroid disease was ruled out and the patient was not receiving steroids. The glomerular filtration rate was measured with Tc-99 diethylenetriaminepentaacetic acid (DTPA) scintigraphy, which yielded a value of 135 mL/min/1.73 m<span class="elsevierStyleSup">2</span>, within the normal range.</p><p id="par0020" class="elsevierStylePara elsevierViewall">The third patient was a young woman aged 20 years with leukaemia secondary to osteosarcoma of the right femur, both in remission, who had undergone HSCT 2 years before. In recent follow-up visits, there had been a progressive increase in the levels of cystatin C to up to 1.74 mg/L, while creatinine levels remained stable at 0.5 mg/dL. The patient had normal anthropometric measurements and did not have hypertension. She was in treatment with levothyroxine for hypothyroidism, with adequate control. There were no urinary abnormalities and the renal ultrasound scan showed mild hyperechogenicity. The patient was not on steroid therapy. Suspending the nephrotoxic drugs she was receiving for prophylaxis, acyclovir and posaconazole did not resolve the discrepancy, which prompted measurement of the GFR with Tc-99 DTPA scintigraphy, the result of which was 85 mL/min/1.73 m<span class="elsevierStyleSup">2</span>, a value in between those estimated based on the cystatin C and creatinine levels and indicative of mild chronic renal disease.</p><p id="par0025" class="elsevierStylePara elsevierViewall">Cystatin C is a low molecular weight protein synthesised by all nucleated cells. It is considered the ideal endogenous marker of glomerular filtration, as it is freely filtered in the renal glomeruli and almost completely reabsorbed and catabolized in the proximal tubules, while its levels appear to be independent from sex, age, muscle mass or dietary habits.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> However, cystatin C may be elevated not only in the context of renal impairment, but also of thyroid disorders or with the use of corticosteroids.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> In the field of oncology, it has been found to play opposite roles in multiple types of cancer, as both a tumour suppressor and a tumour promoter.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Thus, cystatin C may have a protective effect by inhibiting the activity of lysosomal cysteine proteinases, which have been found to be associated with tumour progression and metastasis.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Its elevation unrelated to glomerular filtration has been described previously in adults with solid and blood tumours before initiation of treatment<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> and as a result of chemotherapy.<a class="elsevierStyleCrossRef" href="#bib0020"><span class="elsevierStyleSup">4</span></a> Different case series have found a subsequent descent in patients in remission.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a> Thus, cystatin C may be useful as a biomarker<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> and indicator of tumour burden.<a class="elsevierStyleCrossRef" href="#bib0010"><span class="elsevierStyleSup">2</span></a></p><p id="par0030" class="elsevierStylePara elsevierViewall">Last of all, there are specific circumstances in which accurate measurement of the glomerular filtration rate is required, which can be achieved by measurement of an exogenous marker, such as radioactive tracers like Cr-EDTA or Tc-99 DTPA, which yield values that are in agreement with each other, or iodinated contrast agents, such as the plasma clearance of iohexol, which is strongly correlated to the urinary inulin clearance.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a></p><p id="par0035" class="elsevierStylePara elsevierViewall">We present the cases of 3 patients with leukaemia in whom glomerular filtration rate estimates were corroborated using isotopic markers. The discrepancy with the estimates obtained based on the level of creatinine highlight the need to interpret cystatin C levels with caution in the context of malignancy, both at diagnosis and during the follow-up, and the need to introduce new markers in everyday clinical practice that provide a more accurate assessment of glomerular filtration.</p></span>" "pdfFichero" => "main.pdf" "tienePdf" => true "multimedia" => array:1 [ 0 => array:8 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "detalles" => array:1 [ 0 => array:3 [ "identificador" => "at0005" "detalle" => "Table " "rol" => "short" ] ] "tabla" => array:2 [ "leyenda" => "<p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">BMI, body mass index; BP, blood pressure; eGFR, estimated glomerular filtration rate.</p><p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">The eGFR is expressed as mL/min/1.73 m<span class="elsevierStyleSup">2</span> and was calculating based on the creatinine level, cystatin C level or both combined through the Full-Age Spectrum (FAS) equations<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> published in 2016 and 2017, respectively, with the corresponding adjustment for height of the FAS<span class="elsevierStyleInf">crea</span> in patients 1 and 2 (FAS<span class="elsevierStyleInf">crea-height</span>), and the FAS<span class="elsevierStyleInf">combi</span>.</p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Patient \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Diagnosis \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Weight in kg (percentile, z-score) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Height in cm (percentile, z-score) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">BMI in kg/m<span class="elsevierStyleSup">2</span> (percentile, z-score) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">BP in mmHg \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Baseline serum creatinine (mg/dL) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">eGFR based on creatinine (FAS<span class="elsevierStyleInf">crea</span> 2016) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">Cystatin C (mg/L) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">eGFR based on cystatin C (FAS<span class="elsevierStyleInf">cycC</span> 2017) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">eGFR based on creatinine and cystatin C combined (FAS<span class="elsevierStyleInf">combi</span> 2017) \t\t\t\t\t\t\n \t\t\t\t\t\t</th><th class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" scope="col" style="border-bottom: 2px solid black">eGFR based on imaging techniques \t\t\t\t\t\t\n \t\t\t\t\t\t</th></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Acute myelomonocytic leukaemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">40.75 (P42; −0.21) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">147 (P44; −0.16) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">18.86 (P45; −0.15) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">103/53 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.65 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">90 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2.74 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">32 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">47 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">102 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Acute myeloblastic leukaemia \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">39 (P21; −0.81) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">143 (P8; −1.44) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">19.07 (P39; −0.28) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">100/66 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.43 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">131 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.44 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">61 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">86 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">135 \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td-with-role" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t ; entry_with_role_rowhead " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Osteosarcoma/Secondary acute myeloid leukaemia not otherwise specified \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">56 (P43; −0.19) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">157 (P12; −1.19) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">22.72 (P68; 0.48) \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">99/64 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">0.53 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">142 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">1.74 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">51 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">75 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">85 \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab3262293.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Characteristics of the patients.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:6 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Cystatin C can be affected by nonrenal factors: a preliminary study on leukemia" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:5 [ 0 => "S. Demirtaş" 1 => "Ö Akan" 2 => "M. Can" 3 => "E. Elmali" 4 => "H. Akan" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.clinbiochem.2005.10.009" "Revista" => array:5 [ "tituloSerie" => "Clin Biochem." "fecha" => "2006" "volumen" => "39" "paginaInicial" => "115" "paginaFinal" => "118" ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "High serum cystatin C levels in juvenile myelomonocytic leukemia patients without abnormal kidney function" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:6 [ 0 => "W. Shimabukuro" 1 => "S. Hamada" 2 => "T. Oshiro" 3 => "S. Nakada" 4 => "N. Hyakuna" 5 => "K. Nakanishi" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1007/s00467-021-05418-9" "Revista" => array:6 [ "tituloSerie" => "Pediatr Nephrol." "fecha" => "2022" "volumen" => "37" "paginaInicial" => "1687" "paginaFinal" => "1691" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/35059855" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "On the role of cystatin C in cancer progression" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "G. Leto" 1 => "M. Crescimanno" 2 => "C. Flandina" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.lfs.2018.04.013" "Revista" => array:5 [ "tituloSerie" => "Life Sci." "fecha" => "2018" "volumen" => "202" "paginaInicial" => "152" "paginaFinal" => "160" ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Serum cystatin C level can be used to estimate GFR in patients with solid tumors: CON" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:1 [ 0 => "S. Latcha" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1177/23993693221119216" "Revista" => array:5 [ "tituloSerie" => "J Onco-Nephrology." "fecha" => "2022" "volumen" => "6" "paginaInicial" => "115" "paginaFinal" => "118" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Measured glomerular filtration rate: the query for a workable golden standard technique" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "M.M. Speeckaert" 1 => "J. Seegmiller" 2 => "G. Glorieux" 3 => "N. Lameire" 4 => "W. Van Biesen" 5 => "R. Vanholder" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.3390/jpm11100949" "Revista" => array:5 [ "tituloSerie" => "J Pers Med." "fecha" => "2021" "volumen" => "11" "paginaInicial" => "949" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/34683089" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Estimating glomerular filtration rate for the full age spectrum from serum creatinine and cystatin C" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "H. Pottel" 1 => "P. Delanaye" 2 => "E. Schaeffner" 3 => "L. Dubourg" 4 => "B.O. Eriksen" 5 => "T. Melsom" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1093/ndt/gfw425" "Revista" => array:5 [ "tituloSerie" => "Nephrol Dial Transplant." "fecha" => "2017" "volumen" => "2" "paginaInicial" => "497" "paginaFinal" => "507" ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/23412879/0000009900000003/v1_202309061009/S2341287923001655/v1_202309061009/en/main.assets" "Apartado" => array:4 [ "identificador" => "38181" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Scientific letters" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/23412879/0000009900000003/v1_202309061009/S2341287923001655/v1_202309061009/en/main.pdf?idApp=UINPBA00005H&text.app=https://www.analesdepediatria.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S2341287923001655?idApp=UINPBA00005H" ]
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 October | 50 | 39 | 89 |
| 2024 September | 76 | 45 | 121 |
| 2024 August | 96 | 86 | 182 |
| 2024 July | 98 | 30 | 128 |
| 2024 June | 86 | 28 | 114 |
| 2024 May | 96 | 41 | 137 |
| 2024 April | 48 | 40 | 88 |
| 2024 March | 56 | 24 | 80 |
| 2024 February | 56 | 33 | 89 |
| 2024 January | 61 | 30 | 91 |
| 2023 December | 75 | 18 | 93 |
| 2023 November | 69 | 35 | 104 |
| 2023 October | 77 | 31 | 108 |
| 2023 September | 143 | 44 | 187 |
| 2023 August | 107 | 54 | 161 |
Show all
